Your browser doesn't support javascript.
loading
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
Witjas-Paalberends, E Rosalie; Piroddi, Nicoletta; Stam, Kelly; van Dijk, Sabine J; Oliviera, Vasco Sequeira; Ferrara, Claudia; Scellini, Beatrice; Hazebroek, Mark; ten Cate, Folkert J; van Slegtenhorst, Marjon; dos Remedios, Cris; Niessen, Hans W M; Tesi, Chiara; Stienen, Ger J M; Heymans, Stephane; Michels, Michelle; Poggesi, Corrado; van der Velden, Jolanda.
Affiliation
  • Witjas-Paalberends ER; Laboratory for Physiology, VU University Medical Center, Institute for Cardiovascular Research, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. e.paalberends@vumc.nl
Cardiovasc Res ; 99(3): 432-41, 2013 Aug 01.
Article in En | MEDLINE | ID: mdl-23674513
ABSTRACT

AIMS:

Familial hypertrophic cardiomyopathy (HCM), frequently caused by sarcomeric gene mutations, is characterized by cellular dysfunction and asymmetric left-ventricular (LV) hypertrophy. We studied whether cellular dysfunction is due to an intrinsic sarcomere defect or cardiomyocyte remodelling. METHODS AND

RESULTS:

Cardiac samples from 43 sarcomere mutation-positive patients (HCMmut mutations in thick (MYBPC3, MYH7) and thin (TPM1, TNNI3, TNNT2) myofilament genes) were compared with 14 sarcomere mutation-negative patients (HCMsmn), eight patients with secondary LV hypertrophy due to aortic stenosis (LVHao) and 13 donors. Force measurements in single membrane-permeabilized cardiomyocytes revealed significantly lower maximal force generating capacity (Fmax) in HCMmut (21 ± 1 kN/m²) and HCMsmn (26 ± 3 kN/m²) compared with donor (36 ± 2 kN/m²). Cardiomyocyte remodelling was more severe in HCMmut compared with HCMsmn based on significantly lower myofibril density (49 ± 2 vs. 63 ± 5%) and significantly higher cardiomyocyte area (915 ± 15 vs. 612 ± 11 µm²). Low Fmax in MYBPC3mut, TNNI3mut, HCMsmn, and LVHao was normalized to donor values after correction for myofibril density. However, Fmax was significantly lower in MYH7mut, TPM1mut, and TNNT2mut even after correction for myofibril density. In accordance, measurements in single myofibrils showed very low Fmax in MYH7mut, TPM1mut, and TNNT2mut compared with donor (respectively, 73 ± 3, 70 ± 7, 83 ± 6, and 113 ± 5 kN/m²). In addition, force was lower in MYH7mut cardiomyocytes compared with MYBPC3mut, HCMsmn, and donor at submaximal [Ca²âº].

CONCLUSION:

Low cardiomyocyte Fmax in HCM patients is largely explained by hypertrophy and reduced myofibril density. MYH7 mutations reduce force generating capacity of sarcomeres at maximal and submaximal [Ca²âº]. These hypocontractile sarcomeres may represent the primary abnormality in patients with MYH7 mutations.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myosin Heavy Chains / Cardiomyopathy, Hypertrophic, Familial / Cardiac Myosins / Mutation / Myocardial Contraction Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cardiovasc Res Year: 2013 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myosin Heavy Chains / Cardiomyopathy, Hypertrophic, Familial / Cardiac Myosins / Mutation / Myocardial Contraction Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cardiovasc Res Year: 2013 Document type: Article Affiliation country: Netherlands